Current State of Biotech Funding
The biotech industry is experiencing a period of stabilization after the overly enthusiastic investment trends of 2020 and 2021. Experts like Matthias Kleinz, a key figure at UPMC Enterprises, describe this as a "hangover period," where previous investments were significantly above the historical norm, driven by groundbreaking innovations in the previous decade.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
